AJP - Endo AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 263: E489-E492, 1992;
0193-1849/92 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baron, J.
Right arrow Articles by Cutler, G. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baron, J.
Right arrow Articles by Cutler, G. B., Jr

AJP - Endocrinology and Metabolism, Vol 263, Issue 3 E489-E492, Copyright © 1992 by American Physiological Society

ARTICLES

Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits

J. Baron, Z. Huang, K. E. Oerter, J. D. Bacher and G. B. Cutler Jr
Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.

Excess glucocorticoid is a potent inhibitor of epiphysial growth. Several mechanisms have been suggested to explain this growth inhibition, including both direct local effects of glucocorticoid on the epiphysial growth plate and indirect systemic effects. Previous studies do not distinguish which of these proposed mechanisms is actually responsible for the growth suppression in vivo. To resolve this controversy, we developed a method for delivering glucocorticoid directly into the rabbit epiphysial growth plate and for accurately measuring the resulting epiphysial growth rate. Five-week-old male rabbits received a local infusion of dexamethasone phosphate (80 ng/microliters, 1 microliters/h) into one proximal tibial growth plate and an infusion of vehicle into the contralateral growth plate. Growth rate was determined by inserting metal pins into the bone immediately adjacent to the growth plate and measuring the change in distance between pins on serial radiographs. This method permitted growth rates to be measured over intervals as short as 3 days, with an error of approximately 5%. Local dexamethasone administration decreased proximal tibial growth rate by 77% compared with the contralateral vehicle-treated tibia (P less than 0.0001). We conclude that excess glucocorticoid causes a rapid potent inhibition of growth by a direct local action on the growth plate.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
H. C. Owen, S. J. Roberts, S. F. Ahmed, and C. Farquharson
Dexamethasone-induced expression of the glucocorticoid response gene lipocalin 2 in chondrocytes
Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1023 - E1034.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
T Mushtaq and S F Ahmed
The impact of corticosteroids on growth and bone health
Arch. Dis. Child., August 1, 2002; 87(2): 93 - 96.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Takahashi, F. W. Wehrli, L. Hilaire, B. S. Zemel, and S. N. Hwang
In vivo NMR microscopy allows short-term serial assessment of multiple skeletal implications of corticosteroid exposure
PNAS, March 19, 2002; (2002) 62037499.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online